Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

This study has been completed.
Information provided by:
Sheba Medical Center Identifier:
First received: October 6, 2005
Last updated: January 28, 2008
Last verified: January 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2004
  Primary Completion Date: December 2004 (Final data collection date for primary outcome measure)